Opus Genetics, Inc. Net Asset Momentum
Opus Genetics, Inc. net asset momentum. Opus Genetics, Inc. (IRD) recorded a net asset momentum of 128.3% as of December 2025, with net assets of $15.35 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check IRD capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Opus Genetics, Inc. (2019–2025)
Net asset momentum of Opus Genetics, Inc. from 2019 to 2025. This chart tracks Opus Genetics, Inc.'s year-over-year net asset growth across 7 annual reporting periods from 2019 to 2025. The most recent momentum reading is +128.3%, with net assets of $15.35 Million USD as of December 2025. See IRD net asset value for net asset value and shareholders' equity analysis.
Opus Genetics, Inc. Net Asset Momentum by Year (2019–2025)
Opus Genetics, Inc. net asset momentum by year from 2019 to 2025. The table below shows the complete annual net asset history for Opus Genetics, Inc. from 2019 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see IRD stock market capitalisation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $15.35 Million | $50.24 Million | $34.90 Million | ▲ +128.3% |
| 2024 | $6.72 Million | $36.86 Million | $30.14 Million | ▼ -86.5% |
| 2023 | $49.91 Million | $53.95 Million | $4.04 Million | ▲ +7.9% |
| 2022 | $46.24 Million | $48.99 Million | $2.75 Million | ▲ +108.1% |
| 2021 | $22.22 Million | $26.08 Million | $3.85 Million | ▲ +265.0% |
| 2020 | $-13.47 Million | $17.68 Million | $31.15 Million | ▼ -78.1% |
| 2019 | $-7.56 Million | $1.78 Million | $9.34 Million | — |